Current Role and Responsibilities at Bausch Health Companies
Jeff Hartness served as Senior Vice President of Market Access, Commercial Operations, and Government Affairs at Bausch Health Companies, a role he held with increasing responsibility from at least 2020 until his departure in September 2024. In this capacity, he was a part of the company’s Global Executive Committee and was responsible for pricing, contracting, patient access creation, and distribution strategies for Bausch Health products. His portfolio spanned multiple therapeutic areas covered by Bausch, including gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, and international markets.
His leadership encompassed market access strategy formulation and execution, with a focus on ensuring broad patient and healthcare provider access to the company’s pharmaceutical products. His oversight also included commercial operations and governmental affairs, indicating a combination of strategic external relations and internal operational responsibilities crucial to revenue generation and regulatory compliance.
Professional Background and Experience
- Jeff Hartness brought to Bausch Health more than 25 years of experience in pharmaceutical, healthcare, and biotech industries, marked by a consistent focus on market access, commercial leadership, and go-to-market strategy development.
- Prior to joining Bausch Health in 2016 (initially as Vice President before promotion to Senior Vice President in 2020), he spent 15 years at Sanofi Pharmaceuticals. At Sanofi, Hartness held various leadership roles concentrated on market access, national and regional account management, product launch execution, and ultimately led Sanofi’s PBMs (Pharmacy Benefit Managers), Employers, and Specialty Distribution functions.
- He began his career at Pfizer, adding foundational industry experience to his subsequent leadership roles.
Education and Professional Credentials
- Hartness holds a Bachelor of Arts degree from Hanover College.
- He is a Certified Health Insurance Executive, having completed the program through Northwestern University's Kellogg School of Management, which emphasizes expertise in healthcare insurance, reimbursement, and policy environments.
Board Memberships and External Roles
- Besides his executive duties at Bausch Health, Hartness held board positions at Corganics LP and Bryn Pharma LLC since 2022.
- His board memberships highlight his influence in shaping commercialization strategies beyond his primary corporate role, including focus on healthcare innovation and biotech entrepreneurship.
Transition and Recent Career Move
- In September 2024, Jeff Hartness transitioned from Bausch Health to serve as the Chief Commercial Officer at Apogee Therapeutics Inc., a biotech company where he leverages his extensive commercial leadership and market access expertise.
- His tenure at Apogee Therapeutics represents a continuation of his proven track record across commercial operations and corporate leadership roles in biotech.
Relevant Insights Regarding Bausch Health Companies
- Bausch Health Companies is a global pharmaceutical and healthcare products company publicly traded on the NYSE (ticker: BHC). The company is committed to advancing innovation in multiple therapeutic areas and improving patient access worldwide.
- The company underwent leadership reorganization in 2022 with the appointment of CEO Thomas J. Appio and established a full leadership team, including Jeff Hartness in his senior vice president capacity.
- Bausch Health emphasizes direct-to-consumer campaigns and patient access programs, such as recent initiatives for seasonal affective disorder therapies (APLenzin®), aligning closely with Hartness’s market access and commercial operations expertise.
This profile consolidates Jeff Hartness’s strategic leadership in pharmaceutical market access and commercial operations at Bausch Health, underscored by his long-term industry experience, education credentials, and external board engagements. His role was critical in pricing, contracting, and distribution frameworks, ensuring comprehensive patient access to the company’s products within a complex healthcare and regulatory environment.
